Research Interests
alternative medicine
,
cancer/oncogenesis
,
immunology/allergy/inflammatio
,
neurosciences/behavior
,
vaccines
Recent Publications
Monjazeb AM, Ayala D, Jensen C, Case LD, Bourland JD, Ellis TL, McMullen KP, Chan MD, Tatter SB, Lesser GJ, Shaw EG.
A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys.
2012;
82(2):743-748.
Ruiz J, Case D, Enevold G, Rosdhal R, Tatter SB, Ellis TL, McQuellon RP, McMullen KP, Stieber VW, Shaw EG, Lesser GJ.
A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas. J Neurooncol.
2012;
106(3):611-617.
Marshall K, Chan MD, McCoy TP, Aubuchon AC, Bourland JD, McMullen KP, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Ellis TL.
Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife radiosurgery. Neurosurgery.
2012;
70(3):566-573.
Jensen CA, Chan MD, McCoy TP, Bourland JD, deGuzman AF, Ellis TL, Ekstrand KE, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Tatter SB.
Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg.
2011;
114(6):1585-1591.
Aubuchon AC, Chan MD, Lovato JF, Balamucki CJ, Ellis TL, Tatter SB, McMullen KP, Munley MT, Deguzman AF, Ekstrand KE, Bourland JD, Shaw EG.
Repeat gamma knife radiosurgery for trigeminal neuralgia. Int J Radiat Oncol Biol Phys.
2011;
81(4):1059-1065.
Lowell D, Tatter SB, Bourland JD, DeGuzman AF, Ekstrand KE, Ellis TL, Lovato JF, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Chan MD.
Toxicity of gamma knife radiosurgery in the treatment of intracranial tumors in patients with collagen vascular diseases or multiple sclerosis. Int J Radiat Oncol Biol Phys.
2011;
81(4):e519-e524.
Kilburn JM, Ellis TL, Urbanic JJ, Bourland JD, Munley MT, deGuzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD.
Outcomes for gamma knife radiosurgery for brainstem metastases [abstract]. Int J Radiat Oncol Biol Phys.
2011;
81(2 Suppl):S302.
Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG, Chan MD.
Tumor histology predicts patterns of failure and survival in patients with lung cancer treated with gamma knife radiosurgery [abstract]. Int J Radiat Oncol Biol Phys.
2011;
81(2 Suppl):S595.
Leyrer CM, Peiffer AM, Greene-Schloesser DM, Kearns WT, Hinson WH, Tatter SB, Rapp SR, Robbins ME, Shaw EG, Chan MD.
Normal tissue complication modeling of the brain: dose-volume histogram analysis of neurocognitive outcomes of two CCOP trials [abstract]. Int J Radiat Oncol Biol Phys.
2011;
81(2 Suppl):S184-S185.
Loganathan AG, Chan MD, Alphonse N, Peiffer AM, Johnson A, McMullen KP, Urbanic JJ, Saconn PA, Bourland JD, Munley MT, Shaw EG, Tatter SB, Ellis TL.
Clinical outcomes of brain metastases treated with gamma knife radiosurgery with 3.0 T vs. 1.5 T MRI-based treatment planning [abstract]. Neuro Oncol.
2011;
13(Suppl 3):129.
Paulsson AK, Chan MD, Peiffer AM, Hinson WH, Kearns WT, Lesser GJ, Ellis TL, Tatter SB, Shaw EG, McMullen KP.
Decreased CTV margin size does not affect patterns of failure for glioblastoma treated with concurrent radiotherapy and temozolomide [abstract]. Int J Radiat Oncol Biol Phys.
2011;
81(2 Suppl):S183.
Peiffer AM, Leyrer CM, Greene-Schloesser D, Kearns WT, Hinson WH, Tatter SB, Rapp SR, Robbins ME, Shaw EG, Chan MD.
Normal tissue complication modeling of the brain: dose-volume histogram analysis of neurocognitive outcomes of two CCOP trials [abstract]. Neuro Oncol.
2011;
13(Suppl 3):73.
Vern-Gross TZ, McMullen KP, Case LD, Bourland JD, Ellis TL, Lawrence JA, Tatter SB, Shaw EG, Urbanic JJ, Chan MD.
Patterns of failure in patients receiving gamma knife radiosurgery for breast carcinoma to the brain [abstract]. Int J Radiat Oncol Biol Phys.
2011;
81(2 Suppl):S216-S217.
Vern-Gross TZ, McMullen KP, Case LD, Bourland JD, Ellis TL, Lawrence JA, Tatter SB, Shaw EG, Urbanic JJ, Chan MD.
Patterns of failure in patients receiving gamma knife radiosurgery for breast carcinoma to the brain [abstract]. Neuro Oncol.
2011;
13(Suppl 3):127.
Attia A, Case LD, D'Agostino R Jr, Lesser GJ, McMullen K, Naughton MJ, Rapp SR, Rosdhal R, Shaw EG.
Phase II study of ginkgo biloba in irradiated brain tumor survivors: effects on quality of life (QOL), mood, and cognitive function [abstract]. J Clin Oncol.
2010;
28(Suppl):e12523.
Rapp SR, Case LD, Loghin ME, Meyers CA, Saphner TJ, Sleckman BG, Stieber VW, Atkins JN, Giguere JK, Shaw EG.
Correlation of cognitive symptoms with cognitive performance among brain cancer patients after radiation therapy [abstract]. J Clin Oncol.
2010;
28(Suppl 7):abstr 2084.
Case LD, Naughton MJ, Lesser GJ, Rapp SR, Vitolins M, Sheidler VR, Enevold GL, Shaw EG.
Recruitment and retention in the Wake Forest University CCOP Research Base [abstract]. J Clin Oncol.
2010;
28(Suppl):e19543.
Naughton MJ, Case LD, Meyers CA, Loghin ME, Shaw EG, Saphner TJ, Sleckman BG, Giguere JK, Lesser GJ, Rapp SR.
Quality of life (QOL) and cognitive performance among irradiated brain cancer patients [abstract]. J Clin Oncol.
2010;
28(Suppl 7):abstr 9131.
Lesser GJ, Case LD, Stark N, Williford SK, Giguere JK, Garino A, Naughton MJ, Vitolins M, Lively M, Shaw EG.
A randomized double-blind placebo-controlled study of oral coenzyme Q10 to relieve self-reported cancer-treatment-related fatigue in newly diagnosed breast cancer patients [abstract]. J Clin Oncol.
2010;
28(15 Suppl):9006.
Vitolins M, Lesser GJ, Case LD, Williford SK, Giguere JK, Garino A, Naughton MJ, Lively M, Melin SA, Shaw EG.
Self-reported compliance compared to biomarker levels of vitamin E in breast cancer patients participating in a CoQ10 clinical trial [abstract]. J Clin Oncol.
2010;
28(15 Suppl):e19524.
High KP, Case LD, Siegel RD, Metzner-Sidurski J, Krauss JC, Chinnasami B, Sanders GH, Rousey S, Lesser GJ, Shaw EG.
A phase III randomized, double-blind, placebo controlled trial of North American (NA) ginseng (Panax quinquefolium) extract (CVT-E002) in patients with chronic lymphocytic leukemia: effect on respiratory infection and antibiotic use [abstract]. J Clin Oncol.
2010;
28(15 Suppl):6578.
Wang M, Cairncross G, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, et al.
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. Int J Radiat Oncol Biol Phys.
2010;
77(3):662-669.
Saconn PA, Shaw EG, Chan MD, Squire SE, Johnson AJ, McMullen KP, Tatter SB, Ellis TL, Lovato J, Bourland JD, Ekstrand KE, DeGuzman AF, Munley MT.
Use of 3.0-T MRI for stereotactic radiosurgery planning for treatment of brain metastases: a single-institution retrospective review. Int J Radiat Oncol Biol Phys.
2010;
78(4):1142-1146.
Lowell DA, Shaw EG, Bourland JD, de Guzman AF, Ekstrand KE, Ellis TL, McMullen KP, Munley MT, Tatter SB, Chan MD.
Analysis of toxicity in patients with collagen vascular diseases or multiple sclerosis treated with gamma knife radiosurgery for intracranial tumors [abstract]. Int J Radiat Oncol Biol Phys.
2010;
78(3 Suppl):S269-S270.
Marshall KM, Chan MD, Ellis TL, Aubuchon A, Balamucki CJ, Bourland JD, McCoy TP, McMullen KP, Shaw EG, Tatter SB.
Predictive variables for successful treatment of trigeminal neuralgia with radiosurgery [abstract]. Int J Radiat Oncol Biol Phys.
2010;
78(3 Suppl):S8.
McMullen KP, Harris S, Lovato J, Ellis TL, Tatter SB, Urbanic J, Bourland JD, Shaw EG, Chan MD.
Salvage radiosurgery for patients with small cell lung cancer after previous whole brain radiations [abstract]. Int J Radiat Oncol Biol Phys.
2010;
78(3 Suppl):S274-S275.
Lawrence MV, Rossi P, Powell D, Ekstrand KE, deGuzman AF, Munley MT, Ellis TL, Tatter SB, Stieber VW, McMullen KP, Shaw EG, Bourland JD.
Relationship between radiosurgery conformity indices and acoustic neuroma tumor volume. In: McDermott MW, ed. Radiosurgery.
New York: Karger;
2010:
95-99.
Wentworth S, Pinn M, Bourland JD, DeGuzman AF, Ekstrand K, Ellis TL, Glazier SS, McMullen KP, Munley M, Stieber VW, Tatter SB, Shaw EG.
Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors. Int J Radiat Oncol Biol Phys.
2009;
73(1):208-213.
Attia A, Chan M, Seif D, Russell GB, Bourland JD, Deguzman A, Ellis T, McMullen K, Tatter S, Shaw EG.
Treatment of atypical meningiomas with gamma knife radiosurgery: the role of conformality index and margin dose [abstract]. Int J Radiat Oncol Biol Phys.
2009;
75(3 Suppl 1):S226-S227.
Aubuchon AC, Chan M, Lovano J, McMullen K, Ellis T, Tatter S, Bourland J, Deguzman A, Munley M, Shaw E.
Dorsal root entry zone dose predicts efficacy and toxicity for patients receiving a second radiosurgical treatment for recurrent trigeminal neuralgia [abstract]. Int J Radiat Oncol Biol Phys.
2009;
75(3 Suppl 1):S240.
Jensen CA, Chan MD, McCoy TP, Shaw EG, McMullen KP, Ellis TL, Munley MT, Bourland JD, De Guzman AF, Tatter SB.
Adjuvant radiosurgery after resection of a brain metastasis allows for the delay or elimination of whole brain radiotherapy [abstract]. Int J Radiat Oncol Biol Phys.
2009;
75(3 Suppl 1):S226.
Wang M, Cairncross G, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Souhami L, Laperriere N, Mehta M, et al.
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: Radiation Therapy Oncology Group trial 940 [abstract]. J Clin Oncol.
2009;
27(15 Suppl):e20519.
Cairncross G, Wang M, Chang S, Shaw E, Jenkins R, Scheithauer B, Buckner J, Fink K, Mehta M, Curran W.
A randomized trial or chemotherapy plus radiotherapy (RT) versus RT alone for anaplastic oligodendroglioma (RTOG 9402): the perspective of longer follow-up [abstract]. Int J Radiat Oncol Biol Phys.
2008;
72(1 Suppl):S7-S8.
Monjazeb AM, Bourland JD, Case LD, Ellis TL, Lesser GJ, McMullen KP, Munley M, Tatter SB, Shaw EG.
A phase I dose escalation study of IMRT field-in-field boost for newly diagnosed glioblastoma multiforme (GBM) [abstract]. Int J Radiat Oncol Biol Phys.
2008;
72(1 Suppl 1):S227.
Squire SE, Ellis TL, Shaw EG, Tatter SB, McMullen KP.
Tumor-related facial pain: response to gamma knife radiosurgery [abstract]. Int J Radiat Oncol Biol Phys.
2008;
72(1 Suppl):S225.
Shaw EG, Berkey B, Coons SW, Bullard D, Brachman D, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, et al.
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg.
2008;
109(5):835-841.
Shaw E, Wang MH, Coons SW, Brachman D, Buckner L, Stelzer K, Barger G, Brown P, Gilbert MR, Mehta M.
Radiation therapy (RT) versus RT plus procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG): Radiation Therapy Oncology Group (RTOG) Protocol 9802 [abstract]. Neuro Oncol.
2008;
10(5):884-885.
Squire S, Center B, Ellis T, Shaw E, Tatter S, McMullen K.
Gamma knife stereotactic radiosurgery for brain metastases: timing of posttreatment MRI [abstract]. Neuro Oncol.
2008;
10(5):889.
Lesser GJ, Case D, Ottery F, McQuellon R, Choksi JK, Sanders G, Rosdhal R, Shaw EG.
A phase III randomized study comparing the effects of oxandrolone (Ox) and megestrol acetate (Meg) on lean body mass (LBM), weight (wt) and quality of life (QOL) in patients with solid tumors and weight loss receiving chemotherapy [abstract]. J Clin Oncol.
2008;
26(15 Suppl Pt I):505s.
Gunderson LL, Tepper JE, Ang KK, Choy H, Harris JR, Kun LE, Mauch P, Shaw EG, Thomas GM, Zietman AL.
. In: Clinical radiation oncology. 2nd ed.
Philadelphia: Elsevier Churchill Livingstone;
2007:
.
Shaw EG, Debinski W, Robbins ME.
Central nervous system tumors: overview. In: Gunderson LL, Tepper JE, eds. Clinical radiation oncology. 2nd ed.
Philadelphia: Elsevier Churchill Livingstone;
2007:
459-492.
Brown PD, Shaw EG.
Low-grade gliomas. In: Gunderson LL, Tepper JE, eds. Clinical radiation oncology. 2nd ed.
Philadelphia: Elsevier Churchill Livingstone;
2007:
493-514.
Stieber VW, Shaw EG.
Spinal cord tumors. In: Gunderson LL, Tepper JE, eds. Clinical radiation oncology. 2nd ed.
Philadelphia: Elsevier Churchill Livingstone;
2007:
591-612.
Lesser GJ, Stieber V, Case D, Enevold G, Rosdhal R, Tatter S, Ellis T, McMullen K, Shaw E.
A phase II trial of thalidomide (Thal) and procarbazine (Pro) in adults with recurrent or progressive malignant gliomas (MG) [abstract]. J Clin Oncol.
2007;
25(18 Suppl Pt I):91s.
Stieber V, Robbins M, deGuzman A, Tatter S, Ekstrand K, McMullen K, Branch C, Shaw E, Bourland JD, Lovato J, Munley M, Ellis T, et al.
Determination of a clinical value for the repair half-time (T1/2) of the trigeminal nerve based on outcome data from gamma knife radiosurgery for facial pain. Radiat Res.
2007;
168(2):143-148.
Pinn M, Bourland JD, Ellis T, Deguzman A, Ekstrand K, McMullen K, Glazier S, Munley M, Stieber V, Tatter S, Shaw E, et al.
Results of stereotactic radiosurgery for NF2 patients with acoustic neuroma [abstract]. Neuro Oncol.
2007;
9(4):587.
Wentworth S, Ellis T, Glazier S, McMullen K, Stieber V, Tatter S, Shaw E.
Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors [abstract]. Neuro Oncol.
2007;
9(4):581.
Butler JM Jr, Case LD, Frizzell B, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG, et al.
A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys.
2007;
69(5):1496-1501.
Lally BE, Shaw EG, Knisely JPS, Blackstock AW, Robbins MC, Geiger AM.
Low grade gliomas: demographic, tumor and treatment factors associated with survival [abstract]. Int J Radiat Oncol Biol Phys.
2007;
69(3 Suppl):S185.
Wentworth S, Ellis TL, Glazier S, McMullen KP, Stieber VW, Tatter SB, Shaw EG.
Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors [abstract]. Int J Radiat Oncol Biol Phys.
2007;
69(3 Suppl):S248-S249.
Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperierre N, et al.
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol.
2006;
24(18):2707-2714.
Rogers LR, Rock JP, Sills AK, Vogelbaum MA, Suh JH, Ellis TL, Stieber VW, Asher AL, Fraser RW, Shaw EG, et cl.
Results of a phase II trial of the GliaSite Radiation Therapy System for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg.
2006;
105(3):375-384.
Bourland J, Flowers K, Huey K, Shaw E.
Dedicated PET-CT and MR-simulators in a state-of-the-art radiation treatment facility [abstract]. Med Phys.
2006;
33(6):2165.
Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Shaw EG, et al.
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res.
2006;
66(20):9852-9861.
Kantarci OH, Daugherty WP, Rodriguez FJ, Shaw EG, Parisi JE, Atkinson JL, Lucchinetti CF.
Primary amyloidoma of the brain treated with radiation therapy [abstract]. Brain Pathol.
2006;
16(Suppl 1):S116.
Balamucki CJ, Stieber VW, Ellis TL, Tatter SB, DeGuzman AF, McMullen KP, Lovato J, Shaw EG, Ekstrand KE, Bourland JD, Munley MT, Robbins M, Branch C.
Does dose rate affect efficacy? The outcomes of 256 gamma knife surgery procedures for trigeminal neuralgia and other types of facial pain as they relate to the half-life of cobalt. J Neurosurg.
2006;
105(5):730-735.
Jenkins RB, Ballman KV, Giannini C, Arusell RM, Blair H, Passe S, Flynn H, Brown P, Shaw EG, Buckner JC.
Diagnostic and prognostic significance of a t(1;19)(ql0;pl0) in patients (pts) with low-grade oligodendrogliama and astrocytoma: NCCTG 94-72-53 [abstract]. J Clin Oncol.
2006;
24(18 Suppl Pt I):59s.
Shaw EG, Berkey B, Coons SW, Brachman D, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta M.
Initial report of Radiation Therapy Oncology Group (RTOG) 9802: prospective studies in adult low-grade glioma (LGG) [abstract]. J Clin Oncol.
2006;
24(18 Suppl Pt I):58s.
Kim PK, Ellis TL, Stieber VW, McMullen KP, Shaw EG, McCoy TP, D'Agostino RB, Bourland JD, Deguzman AF, Ekstrand KE, Raber MR, Tatter SB.
Gamma Knife surgery targeting the resection cavity of brain metastasis that has progressed after whole-brain radiotherapy. J Neurosurg.
2006;
105(Suppl):75-78.
Daniels TB, Brown PD, Ballman K, Felton S, Buckner J, Arusell RM, Curran WJ, Earle JD, Shaw EG.
Validation of EORTC prognostic factors for adults with low grade glioma: a report utilizing intergroup 86-72-51 [abstract]. Int J Radiat Oncol Biol Phys.
2006;
66(3 Suppl):S83.
McMullen KP, Papagikos MA, Glazier SS, McLean TW, Maldjian JA, Shaw EG.
Pseudo-progression based on MRI changes following radiation therapy for pilocytic astrocytoma [abstract]. Int J Radiat Oncol Biol Phys.
2006;
66(3 Suppl):S243-S244.
Papagikos MA, McMullen KP, Glazier SS, McLean TW, Maldjian JA, Shaw EG.
MRI pseudo-progression following radiation therapy for pilocytic astroctyoma [abstract]. Neuro Oncol.
2006;
8(4):487-488.
Shaw EG, Berkey B, Coons SW, Brachman D, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta M.
Update of an RTOG prospective study of observation in completely resected adult low-grade glioma [abstract]. Neuro Oncol.
2006;
8(4):452.
Shaw EG, Berkey B, Coons SW, Brachman D, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta M.
Radiation therapy oncology group (RTOG) protocol 9802: radiation therapy (RT) alone versus RT plus PCV chemotherapy in adult lowgrade glioma (LGG) [abstract]. Neuro Oncol.
2006;
8(4):489-490.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.